Wednesday, January 20, 2016

UNCLEAN HANDS AT THE FDA/CDRH: CASE NO. 1:15-cv-20442-JLK KEETON V. ETHICON ET.AL., CDRH BRANCH CHIEF DAVID KRAUSE IS EX-CONSULTANT FOR @ETHICON @JNJNEWS: PROLIFT PELVIC MESH CLEARANCE 2008 = "ATHOS PROJECT" 2002

Corruption, Conspiracy, Collusion has become the norm at the U.S. Food and Drug Administration's Center for Devices and Radiologic Health (FDA's CDRH). "FDA APPROVED" = INDUSTRY TAINTED! @AlexGorsky and his @JNJ minions are EVERYWHERE at the FDA/CDRH, our nations "protector" of the public health.

@JNJ is not the only major device maker "tainting" the FDA's CDRH. Boston Scientific (@BSC) bought and sold thousands of pounds of Chinese counterfeited Marlex HGX-030-01 polypropylene resin to manufacture their synthetic surgical meshes for hernia repair, bladder suspension and pelvic organ prolapse repair. Case No. 2:16-cv-0265, U.S. District Court for the Southern District of West Virginia, Teresa L. Stevens v. Boston Scientific Corporation, et. al.

Who cleared Marlex HGX-030-01 for @BSC's 510(k)081048 pelvic mesh at the FDA's CDRH? You guessed it....DAVID KRAUSE....summer 2008, exactly the same time period Krause supervised the clearance of Ethicon's defective Prolift pelvic mesh (2007-2008). Boston Scientific sells a surgical mesh that is Chinese "Dry Wall" for Humans.

DISGUST is the operative word.

Who supervises DAVID KRAUSE? JEFFREY SHUREN, M.D., J.D., Director of the Center for Devices and Radiologic Health, the same man who authorized the surveillance of 9 whistleblower scientists who objected to the clearance of General Electric (GE) and other medical devices they believed were UNSAFE for patients. The same man and the same government institution that is charged with the safety of the public health.

Is Case No. 1:15-cv-20442-JLK KEETON V. ETHICON et. al. enough to stop the harm?

THE TAINT OF INDUSTRY AT THE FDA'S CDRH MUST BE STOPPED BY CONGRESS!

#DEADWOMENMATTER

NONE OF THIS IS OKAY! LAWLESSNESS REIGNS AT THE FDA'S CDRH!!

P.S. @StateFarm, the Number 7 institutional investor in @JNJ to the tune of almost $4 Billion dollars. Birds of a feather?

No comments: